Concepedia

Murali Venugopalan

MV

8

Publications

760

Citations

8

H-Index

1991

Active since

Affiliations

Eli Lilly (United States)(Current)

Children's Hospital of Los Angeles

Murali Venugopalan is an author at Eli Lilly (United States) specializing in medicine, pharmacology, and tumor biology.

Top concepts

Publications per year

1991–2006

8

Publications

8

Identification of an Estrogen Response Element Activated by Metabolites of 17β-Estradiol and Raloxifene

Na Yang, Murali Venugopalan, Sushant Hardikar et al. · Science · 1996 · 429 citations

Synthesis and Pharmacology of Conformationally Restricted Raloxifene Analogues:  Highly Potent Selective Estrogen Receptor Modulators

Timothy A. Grese, Lewis D. Pennington, James P. Sluka et al. · Journal of Medicinal Chemistry · 1998 · 126 citations

Loss of heterozygosity for alleles on chromosome II in cervical carcinoma.

Eri S. Srivatsan, B C Misra, Murali Venugopalan et al. · PubMed · 1991 · 61 citations

Identification of an Estrogen Response Element Activated by Metabolites of 17 beta-Estradiol and Raloxifene

Na Yang, Murali Venugopalan, Sushant Hardikar et al. · Obstetrical & Gynecological Survey · 1997 · 56 citations

, , +21

Inhibition of MG-63 cell proliferation and PDGF-stimulated cellular processes by inhibitors of phosphatidylinositol 3-kinase

James E. Thomas, Murali Venugopalan, Rachelle Galvin et al. · Journal of Cellular Biochemistry · 1997 · 32 citations

, , +17

Rows per page

1–5 of 8